Related Experiment Video
Updated: Jul 9, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
Qi Zhang1, Chenying Yang2, Xingsu Gao1
1Department of Public Health, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Phytochemicals, natural compounds from plants, enhance cancer immunotherapy by targeting immune checkpoints like PD-1/PD-L1. Combining phytochemicals with immune checkpoint inhibitors boosts anti-tumor effects and T-cell infiltration.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Immune checkpoint blockade is a key cancer therapy.
- Combining therapies aims to improve efficacy and reduce side effects.
- Phytochemicals show anti-cancer properties and modulate the tumor microenvironment.
Purpose of the Study:
- To review immune checkpoint molecules as cancer therapeutic targets.
- To assess phytochemicals' impact on PD-1/PD-L1 immune checkpoints.
- To document combination effects of phytochemicals and immune checkpoint inhibitors.
Main Methods:
- Literature review of clinical and preclinical studies.
- Analysis of phytochemicals' effects on cancer cell lines and in vivo models.
- Examination of phytochemicals' modulation of tumor microenvironment and immune cells.
Main Results:
- Phytochemicals exhibit antiproliferative, proapoptotic, anti-migratory, and antiangiogenic effects.
- Phytochemicals decrease programmed cell death ligand-1 (PD-L1) expression.
- Combined phytochemicals and PD-1 inhibitors enhance tumor growth inhibition and T-cell infiltration.
Conclusions:
- Phytochemicals represent a promising strategy to enhance cancer immunotherapy.
- Targeting PD-1/PD-L1 with phytochemicals and inhibitors offers synergistic anti-cancer effects.
- Further research into phytochemical-based combination therapies is warranted for various malignancies.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Tumor Immunotherapy
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Negative Regulator Molecules
Abnormal Proliferation
Inhibition of Cdk Activity

